Search Results 841-850 of 15270 for alt

1. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

2. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

   AST or ALT >5 times UNL; For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis ...

3. Liver transplant - Doctors & Departments - Mayo Clinic

   Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

4. Testing A Standardized Approach To Surgery And Chemotherapy For Type I Pleuropulmonary Blastoma Or The Addition Of An Anti-cancer Drug, Topotecan, To The Usual Treatment For Types II And III Pleuropulmonary Blastoma - Mayo Clinic

   ... [ALT]) ≤ 135 U/L. Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L. Shortening fraction of ≥ 27% by ...

5. Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) - Mayo Clinic

   ... (ALT, AST, and total bilirubin). Have ingested grapefruit juice or grapefruit products within a 7-day period before Day -1. Participating Mayo Clinic ...

6. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   ... ALT ≤ 2.5 x ULN ; Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within ...

7. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 2 x ULN; Albumin ≥ 3 g/dl; Serum testosterone ≤ 50 ng/dL (1.7 nmol/L). Participating ...

8. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

   ALT or AST > 3 times the upper limit of normal range, or severe hepatic impairment;; Hemoglobin < 100 g/L;; NT-proBNP ≥ 500 pg/mL. If one of these criteria ...

9. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Non-squamous NSCLC Without AGA - Mayo Clinic

   Except in the setting of HBV, ALT and AST ≤ 2.5 × ULN; for participants with hepatic metastases, ALT and AST ≤ 5 × ULN. See Exclusion Criterion 10 for ...

10. A Study Of CGM In GBM - Mayo Clinic

    AST and ALT ≤2.5 × ULN. Total bilirubin ≤1.5 × ULN. Willingness and ability to comply with CGM device use and attend dietary counseling sessions as part of ...